Sofwave Medical Ltd. (IL:SOFW)
TASE:SOFW
Want to see IL:SOFW full AI Analyst Report?
SOFW Stock Chart & Stats
2800.00
-0.53(-3.47%)
At close: 4:00 PM EST
2800.00
-0.53(-3.47%)
Day’s Range― - ―
52-Week Range1,900.00 - 4,869.00
Previous CloseN/A
Volume25.73K
Average Volume (3M)26.78K
Market Cap
₪1.55B
Enterprise Value499.79M
Total Cash (Recent Filing)₪35.49M
Total Debt (Recent Filing)₪1.44M
Price to Earnings (P/E)84.6
Beta0.54
Next Earnings
Aug 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.22
Shares Outstanding36,132,732
10 Day Avg. Volume28,238
30 Day Avg. Volume26,779
Financial Highlights & Ratios
PEG Ratio-0.22
Price to Book (P/B)9.34
Price to Sales (P/S)3.22
P/FCF Ratio21.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSustained ~75% gross margins reflect strong pricing power and low direct costs for an energy-based device business. High margins provide durable earnings leverage as revenue scales, supporting reinvestment in R&D, marketing, and service without requiring outsized revenue growth to remain profitable.
Strong Free Cash FlowA multi-year turnaround to positive operating and free cash flow demonstrates improving cash conversion and operational stability. Meaningful FCF gives management flexibility to fund working capital, service customers, invest in product development, and limit reliance on external financing.
Very Low LeverageA conservatively financed balance sheet with minimal debt provides resilience through cyclical demand and supports strategic optionality. Low leverage reduces interest burden, preserves cash flow for growth initiatives, and lowers the odds of forced equity raises during temporary downturns.
Bears Say
Uneven Revenue GrowthVolatile top-line growth indicates adoption and demand are not yet consistently high. For a device-driven model, uneven sales cycles make forecasting installed-base expansion and recurring consumable revenue harder, complicating capacity, marketing, and long-term revenue visibility.
Installed-Base DependenceBusiness economics rely on building an installed base to generate recurring consumable and service revenue. Slow device placements or low utilization weaken recurring streams; long replacement cycles for medical devices can delay revenue conversion and make growth lumpy over multi-quarter horizons.
Cash Conversion Timing DragWhile absolute cash flow is positive, inconsistent conversion implies working-capital sensitivity. Seasonal or timing mismatches between device sales, consumable revenue, and receivables can strain liquidity during growth phases and raise the need for short-term funding or stricter receivables management.
Sofwave News
SOFW FAQ
What was Sofwave Medical Ltd.’s price range in the past 12 months?
Sofwave Medical Ltd. lowest stock price was 1900.00 and its highest was 4869.00 in the past 12 months.
What is Sofwave Medical Ltd.’s market cap?
Sofwave Medical Ltd.’s market cap is ₪1.55B.
When is Sofwave Medical Ltd.’s upcoming earnings report date?
Sofwave Medical Ltd.’s upcoming earnings report date is Aug 11, 2026 which is in 81 days.
How were Sofwave Medical Ltd.’s earnings last quarter?
Sofwave Medical Ltd. released its earnings results on May 05, 2026. The company reported 10.9 earnings per share for the quarter, beating the consensus estimate of N/A by 10.9.
Is Sofwave Medical Ltd. overvalued?
According to Wall Street analysts Sofwave Medical Ltd.’s price is currently Overvalued.
Does Sofwave Medical Ltd. pay dividends?
Sofwave Medical Ltd. does not currently pay dividends.
What is Sofwave Medical Ltd.’s EPS estimate?
Sofwave Medical Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sofwave Medical Ltd. have?
Sofwave Medical Ltd. has 36,132,732 shares outstanding.
What happened to Sofwave Medical Ltd.’s price movement after its last earnings report?
Sofwave Medical Ltd. reported an EPS of 10.9 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 7.99%.
Which hedge fund is a major shareholder of Sofwave Medical Ltd.?
Currently, no hedge funds are holding shares in IL:SOFW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sofwave Medical Ltd.
Sofwave Medical Ltd. develops an ultrasound technology for treating fine lines and wrinkles in Israel and internationally. It offers non-invasive skin treatment aesthetic medical devices to physicians. The company was incorporated in 2015 and is based in Yokne'am Illit, Israel.